Open Questions in the Management of Nodular Lymphocyte Predominant Hodgkin Lymphoma
Localized Nodular Lymphocyte Predominant Hodgkin Lymphoma is a rare disease with an overall good prognosis but frequent late relapses. Due to it’s rarity there is no standard therapeutic approach and pathological diagnosis may be hard. In this paper we discuss the technical aspects of the radiation...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2014-01-01
|
| Series: | Case Reports in Hematology |
| Online Access: | http://dx.doi.org/10.1155/2014/427613 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832553571528212480 |
|---|---|
| author | Marguerite Tyran Laurence Gonzague Reda Bouabdallah Michel Resbeut |
| author_facet | Marguerite Tyran Laurence Gonzague Reda Bouabdallah Michel Resbeut |
| author_sort | Marguerite Tyran |
| collection | DOAJ |
| description | Localized Nodular Lymphocyte Predominant Hodgkin Lymphoma is a rare disease with an overall good prognosis but frequent late relapses. Due to it’s rarity there is no standard therapeutic approach and pathological diagnosis may be hard. In this paper we discuss the technical aspects of the radiation therapy and histological issues. The new fields reductions proposed for classical Hodgkin lymphoma cannot be applied to early stages Nodular Lymphocyte Predominant Hodgkin lymphomas which are usually treated with radiation therapy without systemic chemotherapy. |
| format | Article |
| id | doaj-art-c656df257bbd4152a52c1836bb784c3e |
| institution | Kabale University |
| issn | 2090-6560 2090-6579 |
| language | English |
| publishDate | 2014-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Case Reports in Hematology |
| spelling | doaj-art-c656df257bbd4152a52c1836bb784c3e2025-02-03T05:53:44ZengWileyCase Reports in Hematology2090-65602090-65792014-01-01201410.1155/2014/427613427613Open Questions in the Management of Nodular Lymphocyte Predominant Hodgkin LymphomaMarguerite Tyran0Laurence Gonzague1Reda Bouabdallah2Michel Resbeut3Service de Radiothérapie Institut Paoli-Calmettes, 232 Boulevard Sainte Marguerite, 13009 Marseille, FranceService de Radiothérapie Institut Paoli-Calmettes, 232 Boulevard Sainte Marguerite, 13009 Marseille, FranceService de Radiothérapie Institut Paoli-Calmettes, 232 Boulevard Sainte Marguerite, 13009 Marseille, FranceService de Radiothérapie Institut Paoli-Calmettes, 232 Boulevard Sainte Marguerite, 13009 Marseille, FranceLocalized Nodular Lymphocyte Predominant Hodgkin Lymphoma is a rare disease with an overall good prognosis but frequent late relapses. Due to it’s rarity there is no standard therapeutic approach and pathological diagnosis may be hard. In this paper we discuss the technical aspects of the radiation therapy and histological issues. The new fields reductions proposed for classical Hodgkin lymphoma cannot be applied to early stages Nodular Lymphocyte Predominant Hodgkin lymphomas which are usually treated with radiation therapy without systemic chemotherapy.http://dx.doi.org/10.1155/2014/427613 |
| spellingShingle | Marguerite Tyran Laurence Gonzague Reda Bouabdallah Michel Resbeut Open Questions in the Management of Nodular Lymphocyte Predominant Hodgkin Lymphoma Case Reports in Hematology |
| title | Open Questions in the Management of Nodular Lymphocyte Predominant Hodgkin Lymphoma |
| title_full | Open Questions in the Management of Nodular Lymphocyte Predominant Hodgkin Lymphoma |
| title_fullStr | Open Questions in the Management of Nodular Lymphocyte Predominant Hodgkin Lymphoma |
| title_full_unstemmed | Open Questions in the Management of Nodular Lymphocyte Predominant Hodgkin Lymphoma |
| title_short | Open Questions in the Management of Nodular Lymphocyte Predominant Hodgkin Lymphoma |
| title_sort | open questions in the management of nodular lymphocyte predominant hodgkin lymphoma |
| url | http://dx.doi.org/10.1155/2014/427613 |
| work_keys_str_mv | AT margueritetyran openquestionsinthemanagementofnodularlymphocytepredominanthodgkinlymphoma AT laurencegonzague openquestionsinthemanagementofnodularlymphocytepredominanthodgkinlymphoma AT redabouabdallah openquestionsinthemanagementofnodularlymphocytepredominanthodgkinlymphoma AT michelresbeut openquestionsinthemanagementofnodularlymphocytepredominanthodgkinlymphoma |